fbpx

The Team

Lundbeckfonden Emerge is led by Christian E. Elling who works closely with the team of Lundbeckfonden Ventures and Lundbeckfonden as well as outside resources complementing the skillset of Lundbeckfonden Emerge.

Lundbeckfonden Emerge

Christian Elling

Christian Elling

Managing Partner
Paul Little

Paul Little

Operating Partner
Jette Brandsen Bundgaard

Jette Brandsen Bundgaard

PA / Office Manager

Engebret Lønnum

Student assistant

Lundbeckfonden Emerge

News

AFYX Therapeutics Achieves Primary Endpoint in Phase 2b Trial of Rivelin-CLO in Patients with Oral Lichen Planus
22. April 2020
IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Randomized Trial in First Line Non-small Cell Lung Cancer
25. February 2020
AFYX Therapeutics Presents Results from Rivelin Clinical Proof of Concept Study in Patients with Vulvar Lichen Sclerosus at the 2019 European Academy of Dermatology and Venereology Congress
10. October 2019